Cargando…

Serum protein biomarkers for juvenile dermatomyositis: a pilot study

BACKGROUND: Blood accessible biomarkers to assess disease activity and their response to therapies in Juvenile Dermatomyositis (JDM) are urgently needed. This pilot study aims to identify serum protein biomarkers associated with clinical disease activity in untreated JDM and their response to medica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tawalbeh, Shefa M., Marin, Wilfredo, Morgan, Gabrielle A., Dang, Utkarsh J., Hathout, Yetrib, Pachman, Lauren M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528471/ https://www.ncbi.nlm.nih.gov/pubmed/33015544 http://dx.doi.org/10.1186/s41927-020-00150-7

Ejemplares similares

Serum biomarkers of glucocorticoid response and safety in anti-neutrophil cytoplasmic antibody-associated vasculitis and juvenile dermatomyositis
por: Conklin, Laurie S., et al.
Publicado: (2018)

Comparison of Serum Pharmacodynamic Biomarkers in Prednisone-Versus Deflazacort-Treated Duchenne Muscular Dystrophy Boys
por: Tawalbeh, Shefa, et al.
Publicado: (2020)

Clues to Disease Activity in Juvenile Dermatomyositis: Neopterin and Other Biomarkers
por: Khojah, Amer, et al.
Publicado: (2021)

Increased Otoferlin Expression in B Cells Is Associated with Muscle Weakness in Untreated Juvenile Dermatomyositis: A Pilot Study
por: Bukhari, Ameera, et al.
Publicado: (2023)

Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactive
por: Roberson, Elisha D. O., et al.
Publicado: (2022)

Tandem Mass Tag-Based Serum Proteome Profiling for Biomarker Discovery in Young Duchenne Muscular Dystrophy Boys
por: Alayi, Tchilabalo D., et al.
Publicado: (2020)

Endothelial progenitor cell number is not decreased in 34 children with Juvenile Dermatomyositis: a pilot study
por: Xu, Dong, et al.
Publicado: (2017)

B Cell Lymphocytosis in Juvenile Dermatomyositis
por: Costin, Christopher, et al.
Publicado: (2023)

The von Willebrand Factor Antigen Reflects the Juvenile Dermatomyositis Disease Activity Score
por: Gibbs, Ellie, et al.
Publicado: (2023)

Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne Muscular Dystrophy
por: Hathout, Yetrib, et al.
Publicado: (2019)

Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity
por: Pachman, Lauren M., et al.
Publicado: (2023)

Lower NK cell numbers in children with untreated juvenile dermatomyositis during the COVID-19 pandemic
por: Costin, Christopher, et al.
Publicado: (2023)

Juvenile Dermatomyositis: Association between Nail Fold Capillary End Row Loops Area Under the Curve and Disease Damage Indicators
por: Khojah, Amer, et al.
Publicado: (2023)

Juvenile dermatomyositis: association between nail fold capillary end row loop– area under the curve– and disease damage indicators
por: Khojah, Amer, et al.
Publicado: (2023)

Changes in total body fat and body mass index among children with juvenile dermatomyositis treated with high-dose glucocorticoids
por: Khojah, Amer, et al.
Publicado: (2021)

Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy
por: Pachman, Lauren M., et al.
Publicado: (2021)

Serum biomarkers associated with baseline clinical severity in young steroid-naïve Duchenne muscular dystrophy boys
por: Dang, Utkarsh J, et al.
Publicado: (2020)

Coding joint: kappa-deleting recombination excision circle ratio and B cell activating factor level: predicting juvenile dermatomyositis rituximab response, a proof-of-concept study
por: Ochfeld, Elisa, et al.
Publicado: (2022)

Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis
por: Duvvuri, Bhargavi, et al.
Publicado: (2023)

Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis
por: Chen, Yi-Wen, et al.
Publicado: (2008)

Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy
por: Ogundele, Michael, et al.
Publicado: (2021)

Biomarker-focused multi-drug combination therapy and repurposing trial in mdx mice
por: Ziemba, Michael, et al.
Publicado: (2021)

Juvenile Dermatomyositis
por: Rhim, Jung Woo
Publicado: (2022)

Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile Dermatomyositis
por: Wienke, Judith, et al.
Publicado: (2020)

Clinical utility of serum biomarkers in Duchenne muscular dystrophy
por: Hathout, Yetrib, et al.
Publicado: (2016)

PReS-FINAL-2131: Hunting for biomarkers in juvenile dermatomyositis
por: Bellutti Enders, F, et al.
Publicado: (2013)

Monitoring change in volume of calcifications in juvenile idiopathic inflammatory myopathy: a pilot study using low dose computed tomography
por: Ibarra, Maria, et al.
Publicado: (2016)

Juvenile Dermatomyositis in Pregnancy
por: Madu, Anthony Emeka, et al.
Publicado: (2013)

The Vasculopathy of Juvenile Dermatomyositis
por: Papadopoulou, Charalampia, et al.
Publicado: (2018)

Juvenile dermatomyositis in Western Switzerland
por: Enders, F Bellutti, et al.
Publicado: (2011)

Respiratory involvement in juvenile dermatomyositis
por: Fabi, M, et al.
Publicado: (2008)

Thrombotic microangiopathy in juvenile dermatomyositis
por: Frolenko, A, et al.
Publicado: (2011)

Effect of TNF-α on human ARPE-19-secreted proteins
por: An, Eunkyung, et al.
Publicado: (2008)

Gastroparesis associated with Juvenile Dermatomyositis
por: Martin, N, et al.
Publicado: (2008)

Calcinosis Universalis in Juvenile Dermatomyositis
por: Chung, Chong Hyuk
Publicado: (2020)

Juvenile Dermatomyositis—Clinical Phenotypes
por: Li, Danyang, et al.
Publicado: (2019)

The Significance of Autoantibodies in Juvenile Dermatomyositis
por: Kwiatkowska, Dominika, et al.
Publicado: (2021)

Clinically Amyopathic Juvenile Dermatomyositis
por: Yıldırım, Deniz Gezgin, et al.
Publicado: (2023)

Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research
por: McCann, Liza J, et al.
Publicado: (2018)

Subclinical pulmonary abnormalities in juvenile dermatomyositis
por: Sallum, Adriana M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qi3dm4hl9049lnv0iumqk8tu7v